RxDoctor Payments Data

Mary Doellman, DO

Otolaryngology · Quincy, ILNPI 1417117854

Payments from drug & device makers

What this record shows

It is spread thinly across 19 manufacturers, the largest accounting for just 23.2%. 2025 is the largest year on record at $3,308, more than ten times the $293 reported in 2019.

$5,983in general payments, 2019–2025

Across 106 payments — averaging $56.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Aerin Medical Inc.$1K
  • Inspire Medical Systems, Inc.$1K
  • Smith+Nephew$1K
  • Integra Lifesciences Corporation$686
  • Stryker$297
  • Sanofi$264
  • plus $1K from 13 others

What the payments were for

  • Travel & lodging$2,44041%
  • Food & beverage$3,54359%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,983 in reported general payments places this provider in the 85th percentile of 390 otolaryngology providers in Illinois.

See all otolaryngology providers in Illinois

Medicare billing

Part B allowed, 2024
$78,400
Medicare patients
352
Services billed
747

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XolairOmalizumab12$31,686
Epinephrine23$5,785
Azelastine Hcl152$3,782
Fluticasone Propionate142$2,014
Famotidine97$1,260
Ipratropium Bromide36$790
Levothyroxine Sodium88$715
Gabapentin12$344
Omeprazole24$277
Mupirocin23$171
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav16$163
Montelukast Sodium28$146
Levocetirizine Dihydrochloride25$125
Methylprednisolone13$92
Prednisone29$80

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Quincy

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →